glutamicum (13) , and this enzyme was shown to be subject to feedback inhibition by L-valine, L-isoleucine, and L-leucine (5, 9, 19) . Expression of the ilvBN genes, which form an operon with ilvC, is controlled by an attenuation mechanism, and it increases about twofold in response to shortage of branchedchain amino acids (19) . On the other hand, expression of the operon is induced by 2-ketobutyrate (5, 19) .
L-Valine-excreting strains of C. glutamicum have been generated by plasmid-bound overexpression of the L-valine biosynthesis genes ilvBNCD or ilvBNCE in combination with a deletion of the ilvA gene encoding TD (23, 24) . Improved production of L-valine was achieved by the introduction of the genes encoding a feedback-resistant AHAS enzyme into Lvaline-producing C. glutamicum strains (9) . Moreover, Radmacher et al. (23) showed that inactivation of the D-pantothenate biosynthesis by deleting the panBC genes led to increased L-valine production of C. glutamicum cultivated under D-pantothenate-limiting conditions. The authors speculated that Dpantothenate limitation leads to an increased drain-off of pyruvate towards the L-valine biosynthetic pathway due to reduced coenzyme A availability for the reaction of the pyruvate dehydrogenase complex (PDHC) (23) . In fact, Escherichia coli pyruvate-overproducing strains have been obtained by inactivation of the PDHC (27, 31) . Increasing the intracellular availability of the precursor pyruvate by decreasing the PDHC activity thus represents an attractive approach for the optimization of L-valine production by C. glutamicum.
Recently, we identified and functionally characterized the E1p subunit of the PDHC in C. glutamicum and showed that this complex is essential for the growth of this organism on glucose, pyruvate, or lactate (26) . In contrast, the PDHC activity was found to be dispensable for the growth of C. glutamicum in medium containing acetate. This growth phenotype opened the possibility to study the effect of PDHC deficiency on metabolite formation from glucose (and acetate) by grow-ing and by nongrowing cells of C. glutamicum. In the present study, we investigate the effect of PDHC inactivation in C. glutamicum on the formation of organic acids and amino acids. We found that resting cells of the PDHC-deficient mutant of C. glutamicum wild type (WT) produce significant amounts of pyruvate, L-valine, and L-alanine. This prompted us to direct the carbon flux more efficiently from glucose to L-valine by additional overexpression of L-valine biosynthetic genes.
MATERIALS AND METHODS
Bacterial strains and plasmids. The strains used in this study were E. coli DH5␣ (10), C. glutamicum WT (i.e., ATCC 13032 from the American Type Culture Collection), and its derivative, C. glutamicum ⌬aceE (26) . Plasmid pJC4ilvBNCE (23) was obtained from L. Eggeling (FZ Jülich).
DNA preparation and transformation. The isolation of plasmid pJC4ilvBNCE from E. coli and C. glutamicum was performed as described before (8) . Plasmid DNA transfer into C. glutamicum was carried out by electroporation, and the recombinant strains were selected on LB-brain heart infusion (BHI) agar plates containing 0.5 M sorbitol and kanamycin (50 g ml Ϫ1 ) (29) . Culture conditions. E. coli was grown aerobically in 2ϫ TY complex medium (25) at 37°C as 50-ml cultures in 500-ml baffled Erlenmeyer flasks on a rotary shaker at 120 rpm. Precultures of C. glutamicum WT, C. glutamicum ⌬aceE, and C. glutamicum ⌬aceE(pJC4ilvBNCE) were grown in 2ϫ TY medium containing 0.5% (wt/vol) potassium acetate. For amino acid fermentations in shake flasks, the cells of an overnight preculture were washed with 0.9% (wt/vol) NaCl and inoculated into CGXII minimal medium (7) to give an initial optical density at 600 nm (OD 600 ) of about 1. The medium contained 4% (wt/vol) glucose and 1% or 1.5% (wt/vol) potassium acetate. Where indicated in Results, 0.5% (wt/vol) BHI powder (Merck) was added to the medium. The plasmid-carrying strains were grown in the presence of kanamycin (50 g ml Ϫ1 ). C. glutamicum was grown aerobically at 30°C as 50-ml cultures in 500-ml baffled Erlenmeyer flasks on a rotary shaker at 120 rpm or as 300-ml cultures in a glass bioreactor (see below).
The batch and fed-batch fermentations were performed at 30°C in a 1-liter glass bioreactor (Biostat B; Braun, Melsungen, Germany). The pH was maintained at 7.0 by online measurement using a standard pH electrode (Mettler Toledo, Giessen, Germany) and the addition of 4 M KOH and 4 M HCl. Foam development was prohibited by manual injection of small amounts (about 20 l) of silicon antifoam (Roth, Karlsruhe, Germany). The dissolved oxygen was measured online by use of a polarimetric oxygen electrode (Mettler Toledo, Giessen, Germany), and it was adjusted to 30% of saturation in a cascade by stirring at 100 to 1,200 rpm and aerating with 1 to 3 liters of air per min. During the fed-batch processes, adequate amounts of 50% (wt/vol) glucose and 50% (wt/vol) potassium acetate were injected (at the time points indicated below [see Fig. 4 
]).
Analytics. One milliliter of the culture was harvested by centrifugation (13,000 rpm, 10 min, room temperature), and the supernatant was used for determination of amino acid, glucose, and/or organic acid concentrations in the culture fluid. The amino acid concentration was determined by reversed-phase highpressure liquid chromatography (on an HP 1100 instrument; Hewlett-Packard, Waldbronn, Germany) with fluorimetric detection (excitation at 230 nm and emission at 450 nm) after automatic precolumn derivatization with ortho-phthaldialdehyde (18) . Separation was carried out at 40°C on a Multohyp octyldecyl silane column (particle size, 5 m; 125 by 4 mm; CS-Chromatographie, Langerwehe, Germany). The elution buffer consisted of a polar phase (0.1 M sodium acetate, pH 7.2) and a nonpolar phase (methanol). Quantification was done by calculation of the concentration by use of an internal standard (L-ornithine at 100 M) and by a 10-point calibration curve for each amino acid. Glucose, acetate, and lactate concentrations were determined by enzymatic tests (Roche Diagnostics, Penzberg, Germany). The pyruvate concentrations were determined enzymatically according to the method of Bergmeyer (1) .
For the measurement of intracellular pyruvate concentrations, the cells were cultivated in 50 ml CGXII medium. Samples of 5 ml were taken for measurements during growth and production phases, at about 9 h and 31 h after inoculation, respectively. All following steps were performed below Ϫ10°C to prevent changes in the metabolome (4, 12) . After centrifugation of the samples at 10,400 ϫ g for 5 min at Ϫ20°C, the cell pellets were resuspended in 5 ml ice-cold NaCl (0.9% [wt/vol]) and centrifuged again. The supernatants were discarded and the cells resuspended in 1 ml methanol (Ϫ80°C) and 1 ml Tris-EDTA buffer (pH 7.0). For cell extraction, 2 ml chloroform was added, and the suspension was shaken for 2 h at Ϫ20°C. After extraction, the pyruvate in the methanol phase was determined by liquid chromatography-tandem mass spectrometry (Finnigan TSQ Quantum Ultra; Thermo) according to the method of Luo et al. (18a) . Quantification was done by external calibration due to the absence of matrix effects in the appropriate dilutions. For the calculation of the intracellular pyruvate concentration, a specific cell volume of 1.95 l/mg was assumed (21) . All intracellular concentrations are based on data from three independent experiments with two replicates of each analytical measurement.
RESULTS
C. glutamicum ⌬aceE forms pyruvate, L-alanine, and L-valine. Previously, we analyzed the C. glutamicum aceE gene, encoding the E1p subunit of the PDHC, and constructed and characterized an E1p-deficient mutant, C. glutamicum ⌬aceE (26) . This mutant carries a deletion in the chromosomal aceE locus, shows no PDHC activity, and is unable to grow on minimal medium containing glucose as the carbon and energy source unless supplemented with acetate. To test C. glutami- cum ⌬aceE for its ability to form organic acids and/or amino acids from glucose and acetate and to compare its metabolite formation with that of the parental C. glutamicum WT, both strains were grown in a 1-liter bioreactor in CGXII medium containing 4% (wt/vol) glucose and 1.5% (wt/vol) potassium acetate, and growth, glucose, and acetate utilization and pyruvate, lactate, and amino acid accumulation were monitored over the course of the experiment. C. glutamicum WT grew with maximal growth rates of 0.36 h Ϫ1 to a final OD 600 of about 65, metabolized glucose and acetate simultaneously, and did not form any of the tested metabolites to concentrations higher than 1 mM (not shown). For the first 6 to 8 hours, C. glutamicum ⌬aceE also grew exponentially, with a maximal growth rate of 0.36 h Ϫ1 , and simultaneously used acetate and glucose. During this growth phase, the strain also did not excrete any of the metabolites tested into the culture broth (Fig. 2) . As expected, the PDHC-deficient mutant stopped growth as soon as the acetate concentration dropped to Ͻ1 mM and the culture reached a maximal OD 600 of about 19. However, the mutant continued to metabolize glucose and, in contrast to C. glutamicum WT, started to produce significant amounts of pyruvate (30 to 35 mM), L-alanine (25 to 30 mM), L-threonine (2 to 5 mM), and L-valine (30 to 35 mM) (Fig. 2) . Lactate, acetate, and amino acids other than L-alanine, L-threonine, and L-valine were not formed in the course of the cultivation of C. glutamicum ⌬aceE. These results show that PDHC deficiency is an ideal condition to breed C. glutamicum strains producing either pyruvate, L-alanine, or L-valine. Furthermore, the results indicate that inactivation of the competing pathways of L-isoleucine biosynthesis and of D-pantothenate synthesis, e.g., by deleting the ilvA and/or panB gene(s), is not necessary for efficient L-valine formation.
L-Valine production by C. glutamicum ⌬aceE strains overexpressing ilv genes. In order to force the carbon flux in C. glutamicum ⌬aceE from pyruvate towards L-valine production, we transformed this strain with plasmid pJC4ilvBNCE. This plasmid carries the genes encoding three of the four enzymes involved in L-valine (and L-isoleucine) biosynthesis (see the introduction) and has previously been used to construct Lvaline-producing derivatives of C. glutamicum WT, C. glutamicum ⌬ilvA, and C. glutamicum ⌬ilvA ⌬panBC (reference 23; also see the introduction). L-Valine fermentations with C. glutamicum ⌬aceE(pJC4ilvBNCE) were carried out in CGXII medium with 0.5% (wt/vol) BHI, 4% (wt/vol) glucose, and 1% (wt/vol) potassium acetate. Figure 3 shows the course of a typical fermentation. The culture grew within 8 h to an OD 600 of about 20, consuming acetate completely (1%) and glucose to a minor part (0.5%). The cells then stopped growth, and they further consumed glucose and accumulated up to about 105 mM L-valine within 64 h. Although C. glutamicum ⌬aceE-(pJC4ilvBNCE) produced relatively high amounts of L-valine, it nevertheless excreted nearly 20 mM pyruvate into the medium, indicating that there is still precursor available for Lvaline production. No L-alanine was formed in C. glutamicum carrying ⌬aceE in combination with plasmid pJC4ilvBNCE. These results show that pyruvate supply on one hand and the enzymes for the L-valine biosynthetic pathway on the other are major bottlenecks for L-valine overproduction by C. glutamicum.
Intracellular pyruvate concentrations in C. glutamicum and its derivatives. The production pattern of C. glutamicum ⌬aceE and C. glutamicum ⌬aceE(pJC4ilvBNCE) suggested that the PDHC deficiency brought about by deletion of the aceE gene might have led to a high intracellular accumulation of pyruvate. To test for this hypothesis, we determined the intracellular pyruvate concentrations in C. glutamicum WT and its derivatives, the ⌬aceE and ⌬aceE(pJC4ilvBNCE) strains, during exponential growth and at the stationary phase, the latter being the production phase for C. glutamicum ⌬aceE and C. glutamicum ⌬aceE(pJC4ilvBNCE). All three strains showed Fed-batch fermentations with C. glutamicum ⌬aceE-(pJC4ilvBNCE). In order to test the suitability of C. glutamicum ⌬aceE(pJC4ilvBNCE) for an improved L-valine production process, we established a fed-batch fermentation based on mixed substrate (Fig. 4) . These fermentations were carried out in CGXII medium containing 0.5% (wt/vol) BHI, 4% glucose, and an initial potassium acetate concentration of 1% (wt/vol). To allow growth to a high cell density, adequate amounts of a 50% (wt/vol) acetate stock solution were repeatedly added (eight times) to the growing cells (Fig. 4) . Using this technique, an OD 600 of about 70 was obtained after 19 h (Fig. 4) . During this growth period, about 20 g glucose/liter was consumed in addition to acetate; however, neither L-valine nor pyruvate was excreted into the medium. After having consumed the last pulse of acetate, the cells started to excrete L-valine, and at time points 20 h and 33 h, we added pulses of 4% (wt/vol) glucose. As shown in Fig. 4 , the cells accumulated about 210 mM L-valine within 21 h with a volumetric productivity of 10.0 mM h Ϫ1 (1.17 g liter Ϫ1 h Ϫ1 ) and a maximal yield of 0.6 mol L-valine per mol of glucose (between 19 h and 33 h in Fig. 4) . The overall yield in the production phase (between 19 h and 40 h) was about 0.5 mol per mol of glucose. In addition to L-valine, the cells also still excreted small amounts of pyruvate (5 mM) into the medium, indicating that L-valine production by C. glutamicum ⌬aceE(pJC4ilvBNCE) can be further increased. Taken together, all these results demonstrate that C. glutamicum ⌬aceE with plasmid-bound overexpression of Lvaline biosynthetic genes is a very useful platform for optimizing L-valine production with C. glutamicum.
DISCUSSION
L-Valine-producing strains of C. glutamicum have previously been obtained by undirected mutagenesis (20, 28) and by overexpression of genes encoding (deregulated) L-valine biosynthetic enzymes, in combination with the deletion of ilvA and/or of the D-pantothenate biosynthetic genes panBC (9, 23, 24) . The knockout of the ilvA gene eliminates TD activity and thus the formation of 2-ketobutyrate, which together with pyruvate is a substrate for L-isoleucine biosynthesis via AHAS, AHAIR, dihydroxyacid dehydratase, and TA. This leads to an isoleucine auxotrophy on the one hand and to an enhanced pyruvate availability on the other. Both these effects have been proposed to be responsible for enhanced L-valine production, since the former should lead to a suspension of the allosteric AHAS inhibition and of the attenuation control of the ilvBNC genes by L-isoleucine (5, 19) and the latter to an enhanced pyruvate flux into the L-valine biosynthetic pathway. As shown here, ilvA deletion (or TD inactivation) is not a prerequisite for effective L-valine production with C. glutamicum, indicating that the allosteric regulation of AHAS and the ilvBNC expression control by intracellular L-isoleucine are not very critical for the L-valine production process. Deletion of the panBC genes in C. glutamicum has been shown to result in pantothenate auxotrophy (23) . Due to the finding that a panC mutant excreted pyruvate and alanine into the growth medium and due to the hypothesis that reduced coenzyme A availability in pantothenate-auxotrophic C. glutamicum strains should lead to reduced PDHC activity, Radmacher et al. (23) speculated that in this mutant increased quantities of precursor are directly available for L-valine synthesis. In accordance with this hypothesis, we here show that a PDHC-deficient mutant of C. glutamicum WT without any further genetic engineering is able to produce significant amounts of L-valine from glucose. In addition, C. glutamicum ⌬aceE excreted significant amounts of pyruvate and L-alanine, indicating that L-valine production in this strain is limited by the reactions from pyruvate to L-valine and not by pyruvate availability. This hypothesis is corroborated by our results obtained with C. glutamicum ⌬aceE carrying the ilvBNCE genes on plasmid pJC4. In batch fermentations, this strain produced much more L-valine, less pyruvate, and no L-alanine, and in fed-batch fermentations, the product spectrum was almost completely shifted towards L-valine. Since C. glutamicum ⌬aceE(pJC4ilvBNCE) in shake flask batch fermentation produced as much L-valine as or even more L-valine than did previously constructed L-valine-producing strains (references 3, 9, and 23; also see below), our results indicate that effective L-valine production with C. glutamicum can easily be attained by optimization of the pyruvate availability and increasing the intracellular content of L-valine biosynthetic enzymes AHAS, AHAIR, and TA. Furthermore, the results show that effective L-valine production neither relies on isoleucine and/or pantothenate auxotrophy nor requires the presence of deregulated L-valine biosynthetic enzymes. Independently of the presence or absence of plasmid pJC4ilvBNCE and independently of the fermentation process, L-valine production in C. glutamicum ⌬aceE was decoupled from growth, i.e., took place only after cessation of the growth, or in other words, after depletion of the acetate required for growth of the mutant. This phenotype is surprising in view of the fact that L-valine (and also L-lysine, L-leucine, L-alanine, and L-threonine) production with C. glutamicum generally occurs in the course of the growth (2, 9, 11). One explanation for the production phenotype of C. glutamicum ⌬aceE might be that the presence of acetate may have a negative effect on glucose uptake and/or on one or several enzymes involved in glycolysis; thus, the pyruvate availability in the growth phase might be restricted to the requirements for cell mass biosynthesis. In favor of this argument, we previously showed that glucose consumption and the carbon flux from external glucose to pyruvate was reduced when C. glutamicum grows on glucose plus acetate instead of on glucose alone (30) . Moreover, we here show that in fact the intracellular pyruvate concentrations in C. glutamicum WT as well as in the aceE deletion mutants were very low in the course of the growth and much higher in the stationary/production phase. Here it is interesting to note that AHAS, the first enzyme in L-valine synthesis from pyruvate, has a relatively weak affinity for pyruvate (K m ϭ 8.3 mM) (5, 16) compared to those of enzymes competing with AHAS for pyruvate, e.g., that of pyruvate carboxylase (K m ϭ 1.3 mM) (22) .
Brik Ternbach et al. (2) recently used fed-batch experiments with C. glutamicum ⌬ilvA ⌬panBC(pJC4ilvBNCD) for model development and improvement of the L-valine fermentation process. In an experiment designed to maximize the total volumetric productivity, the final product concentration was almost 200 mM, and the maximal volumetric productivity was 6.2 mM L-valine per h. However, the cells produced several byproducts, such as L-alanine, L-glycine, and 2-ketoglutarate (2). Leuchtenberger et al. (15) reported on a C. glutamicum mutant (VR3) which was obtained by classical mutagenesis and which produced up to 850 mM L-valine with a yield of 0.3 to 0.4 g per g of sucrose, which is equivalent to 0.45 to 0.6 mol per mol of glucose. Comparing these numbers with the data presented here for the fed-batch fermentation with C. glutamicum ⌬aceE(pJC4ilvBNCE), i.e., a final L-valine concentration of 210 mM, a volumetric productivity of 10.0 mM L-valine per h and a yield of 0.5 to 0.6 mol L-valine per mol of glucose within 21 h of production, the performance of our simple model strain becomes strikingly evident. However, the maximal theoretical yield amounts to 1 mol L-valine per mol of glucose (i.e., 0.65 g per g), indicating that L-valine production with C. glutamicum can be further optimized. Moreover, taking the numbers given above in account, we neglect that C. glutamicum ⌬aceE-(pJC4ilvBNCE) does not produce L-valine in the growth phase. With respect to L-valine process development, the opportunity for a simple growth-decoupled production is a significant advantage allowing for more efficient use of the biocatalyst.
Further approaches to improve L-valine production with C. glutamicum ⌬aceE(pJC4ilvBNCE) will aim at unraveling and overcoming the metabolic or regulatory reason for the nonproduction phenotype during the growth phase to allow both growth-coupled and -decoupled product formation. However, although not yet maximized as L-valine production strains, derivatives of C. glutamicum ⌬aceE may prove useful as costeffective biocatalysts for the production of pyruvate itself and/or of products derived from this intermediate.
